Related Experiment Video

Updated: Feb 13, 2026

Forward Genetic Approaches in Chlamydia trachomatis
09:03

Forward Genetic Approaches in Chlamydia trachomatis

Published on: October 23, 2013

13.3K

PmpI antibody reduces the inhibitory effect of Vp1 on Chlamydia trachomatis infectivity

Jie Ren1,1, Tingting Lian1,1, Lili Shao1,1

  • 1Dermatology and Venereology Department, Tianjin Medical University General Hospital, 154 Anshan Road, Heping District, Tianjin 300052, People's Republic of China.

Canadian Journal of Microbiology
|March 7, 2018
PubMed

Insights

Chlamydia trachomatis infections are common, and treatments are limited. Chlamydia virus CPG1 capsid protein Vp1 shows promise by inhibiting bacterial growth and targeting outer membrane protein PmpI.

Area of Science:

  • Microbiology
  • Virology
  • Immunology

Background:

  • Chlamydia trachomatis is a leading cause of bacterial sexually transmitted infections.
  • Current antibiotic treatments for C. trachomatis are suboptimal, and no vaccine is available.
  • Understanding host-pathogen interactions is crucial for developing new therapeutic strategies.

Purpose of the Study:

  • To investigate the inhibitory effects of Chlamydia virus CPG1 capsid protein Vp1 on C. trachomatis.
  • To elucidate the molecular mechanisms and identify C. trachomatis targets of Vp1.
  • To explore the potential of Vp1 as a therapeutic agent against chlamydial infections.

Main Methods:

  • Cell culture experiments to assess the impact of Vp1 on C. trachomatis growth.
  • Far-western blot and GST pull-down assays to identify Vp1 binding partners.
  • Polyclonal antibody treatment to validate the role of identified targets.

Main Results:

  • Vp1 treatment significantly inhibited C. trachomatis growth and reduced inclusion numbers in cell culture.
  • Vp1 was found to bind to the C. trachomatis outer membrane protein PmpI.
  • Antibody-mediated blocking of PmpI diminished the inhibitory effect of Vp1.

Conclusions:

  • Chlamydia virus CPG1 capsid protein Vp1 exhibits antimicrobial activity against C. trachomatis.
  • C. trachomatis outer membrane protein PmpI is identified as a potential Vp1 receptor involved in its inhibitory mechanism.
  • These findings offer insights into chlamydia-virus interactions and suggest Vp1 as a potential therapeutic candidate.
Keywords:
Chlamydia trachomatisPmpIVp1chlamydia virusinhibition

More Related Videos

Live-Cell Forward Genetic Approach to Identify and Isolate Developmental Mutants in Chlamydia trachomatis10:32

Live-Cell Forward Genetic Approach to Identify and Isolate Developmental Mutants in Chlamydia trachomatis

Published on: June 10, 2020

4.6K
A Human Fallopian Tube Model for Investigation of C. trachomatis Infections09:11

A Human Fallopian Tube Model for Investigation of C. trachomatis Infections

Published on: August 11, 2012

13.4K

Related Concept Videos

Bacterial Phylum Chlamydiae01:29

Bacterial Phylum Chlamydiae

The phylum Chlamydiae or Chlamydiota is composed of a single order, Chlamydiales. This phylum consists entirely of obligate intracellular parasites that infect eukaryotic hosts. While human pathogens within this group have been studied extensively, the phylum encompasses many species capable of interacting with various eukaryotic organisms. Members of Chlamydiae are typically small cocci, approximately 0.5 μm in diameter, and exhibit a distinctive developmental cycle. As is characteristic...
599
Reducing Line Loss01:18

Reducing Line Loss

In a three-phase circuit, line loss is an indicator of energy dissipated as heat due to the resistance of transmission lines. To address this, incorporating transformers into the system—a step-up transformer at the source and a step-down transformer at the load—is a strategic solution. Two three-phase transformers are introduced to improve this.
With a step-up transformer at the source, the voltage is increased, thereby reducing the current in the transmission lines since power loss in...
395
Excitatory and Inhibitory Effects of Neurotransmitters01:29

Excitatory and Inhibitory Effects of Neurotransmitters

When an action potential reaches the presynaptic axon terminal, it releases neurotransmitters from the neuron into the synaptic cleft at a chemical synapse. The released neurotransmitter can be excitatory or inhibitory. The critical criteria commonly used to determine whether a molecule is a neurotransmitter at a chemical synapse are the molecule's presence in the presynaptic neuron. Second, its release is in response to strong presynaptic depolarization. And lastly, the presence of...
13.2K
Antibody Structure01:10

Antibody Structure

Overview
Antibodies, also known as immunoglobulins (Ig), are essential players of the adaptive immune system. These antigen-binding proteins are produced by B cells and make up 20 percent of the total blood plasma by weight. In mammals, antibodies fall into five different classes, which each elicits a different biological response upon antigen binding.
The Y-Shaped Structure of Antibodies Consists of Four Polypeptide Chains
Antibodies consist of four polypeptide chains: two identical heavy...
65.8K
Methods of reducing fever01:22

Methods of reducing fever

The signs and symptoms of fever include hot and dry skin, flushed face, thirst, muscle aches, anorexia, headache, tachycardia, tachypnea, and fatigue. Elevated body temperature is reduced using two methods: pharmacological and nonpharmacological. Proper identification and treatment of the root cause of a fever is of utmost importance.
Pharmacological Methods of Reducing Fever:
1.4K
Adaptations that Reduce Water Loss01:57

Adaptations that Reduce Water Loss

Though evaporation from plant leaves drives transpiration, it also results in loss of water. Because water is critical for photosynthetic reactions and other cellular processes, evolutionary pressures on plants in different environments have driven the acquisition of adaptations that reduce water loss.
28.3K